WAVE Life Sciences (WVE) Tops Q3 EPS by 51c

WAVE Life Sciences (NASDAQ: WVE) reported Q3 EPS of ($0.12), $0.51 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $36.4 million versus the consensus estimate of $10.36 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Deutsche Bank Starts DexCom (DXCM) at Buy
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance